These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17162235)

  • 1. Cost-effectiveness of treating esophageal varices.
    Talwalkar JA
    Clin Liver Dis; 2006 Aug; 10(3):679-89, xi. PubMed ID: 17162235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
    Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
    Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of preventing variceal hemorrhage.
    Post AB
    Hepatology; 2003 Aug; 38(2):534-5; author reply 535. PubMed ID: 12883502
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices.
    Di Pascoli L; Buja A; Bolognesi M; Montagnese S; Gatta A; Gregori D; Merkel C
    World J Gastroenterol; 2014 Aug; 20(30):10464-9. PubMed ID: 25132763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective therapeutic strategy for the management of bleeding gastric fundal varices.
    Matsumoto A; Takimoto K; Kuchide M; Yamauchi Y; Takemura T
    Endoscopy; 2004 Nov; 36(11):1031-2; author reply 1032-3. PubMed ID: 15520927
    [No Abstract]   [Full Text] [Related]  

  • 6. A commonsense approach to esophageal varices.
    Longacre AV; Garcia-Tsao G
    Clin Liver Dis; 2006 Aug; 10(3):613-25, x. PubMed ID: 17162231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
    Imperiale TF; Klein RW; Chalasani N
    Hepatology; 2007 Apr; 45(4):870-8. PubMed ID: 17393528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
    Targownik LE; Spiegel BM; Dulai GS; Karsan HA; Gralnek IM
    Am J Gastroenterol; 2004 Jul; 99(7):1306-15. PubMed ID: 15233670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based medicine approach to beta-blocker therapy in patients with cirrhosis.
    Talwalkar JA; Kamath PS
    Am J Med; 2004 Jun; 116(11):759-66. PubMed ID: 15144913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary prevention of esophageal varices].
    Sieveking CF
    Dtsch Med Wochenschr; 2006 Aug; 131(31-32):1758; author reply 1758. PubMed ID: 16868885
    [No Abstract]   [Full Text] [Related]  

  • 11. The budget impact of endoscopic screening for esophageal varices in cirrhosis.
    Spiegel BM; Esrailian E; Eisen G
    Gastrointest Endosc; 2007 Oct; 66(4):679-92. PubMed ID: 17905009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A balancing view: Should cirrhotic patients with small esophageal varices undergo primary bleeding prophylaxis?
    Carey W
    Am J Gastroenterol; 2009 Sep; 104(9):2136-8. PubMed ID: 19727080
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is..
    Bosch J; Garcia-Tsao G
    Hepatology; 2009 Sep; 50(3):674-7. PubMed ID: 19714716
    [No Abstract]   [Full Text] [Related]  

  • 14. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
    Tiani C; Abraldes JG; Bosch J
    Dig Liver Dis; 2008 May; 40(5):318-27. PubMed ID: 18291732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and therapy of esophageal vascular disorders.
    de Franchis R; Dell'Era A
    Curr Opin Gastroenterol; 2007 Jul; 23(4):422-7. PubMed ID: 17545780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy.
    O'Donnell TF; Gembarowicz RM; Callow AD; Pauker SG; Kelly JJ; Deterling RA
    Surgery; 1980 Nov; 88(5):693-701. PubMed ID: 6776645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost assessments in the management of variceal bleeding.
    Gralnek IM; Jensen DM
    Clin Liver Dis; 1997 May; 1(1):45-58, x. PubMed ID: 15562667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models: do they answer the question?
    Saini SD; Rubenstein JH
    Gastrointest Endosc; 2008 Nov; 68(5):937-9. PubMed ID: 18984101
    [No Abstract]   [Full Text] [Related]  

  • 19. Endoscopy critics vs. endoscopy enthusiasts for primary prophylaxis of variceal bleeding.
    de Franchis R
    Hepatology; 2006 Jan; 43(1):24-6. PubMed ID: 16374843
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of bleeding from oesophageal varices in patients with cirrhosis].
    Krag AA; Møller S; Bendtsen F
    Ugeskr Laeger; 2007 Aug; 169(34):2753-8. PubMed ID: 17878009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.